The authorization means pouches can be marketed to adults 21 or older but doesn’t mean the products are “FDA approved.” ...

Qnovia, Inc., a pharmaceutical company developing inhaled therapeutics across a variety of indication areas leveraging its proprietary inhaled drug delivery platform, the RespiRx™, today announced the ...

His own 16-year-old son is curious about nicotine ... products are used by Britain’s National Health Service, among others. Some even recommended that doctors stop proscribing Vectura-made inhalers.

The U.S. Food and Drug Administration authorized the marketing of 20 Zyn products on Thursday, marking the first such move by ...

Nicotine inhalation system 10mg (4mg delivered ... then reduce gradually over 12 more weeks. Inhaler: peak plasma concentrations of 49ng/mL reached within 15 minutes. Nasal spray: maximum ...

Giving up nicotine can be a brutal experience that can include everything from physical symptoms, such as headache and nausea ...

His own 16-year-old son is curious about nicotine ... products are used by Britain’s National Health Service, among others. Some even recommended that doctors stop proscribing Vectura-made inhalers.

The FDA said "an extensive scientific review" found the products were found to pose lower risks of cancer and other serious ...

This came in order to establish ceiling prices for scheduled formulations of nicotine (for nicotine replacement therapy) ...

Gireesh Babu, New Delhi Saturday, January 18, 2025, 08:00 Hrs [IST] ...